Introduction and Vision Statement: What Do the Frontiers of Thrombosis Reduction Look Like? Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI
Challenges and Emerging Dimensions of Stroke Prevention in the Setting of Atrial Fibrillation (AF): Achieving Balance Between Thromboprophylaxis and Bleeding Reduction Gregory Y.H. Lip, MD, FRCP, FACC, FESC
Stroke Prevention in High Risk Populations-The Evolving Paradigm of Warfarin-Based Therapy: Still Relevant? And for How Long? David A. Garcia, MD
The Emerging Role of Factor Xa and Direct Thrombin Inhibition in Atrial Fibrillation: Mechanisms and Applications for Thrombosis Mitigation Across the CV Disease Spectrum Richard C. Becker, MD
The Emerging Role of Factor Xa and Direct Thrombin Inhibition for the Setting of Secondary Prevention in Acute Coronary Syndrome (ACS) Shamir Mehta, MD, MSc, FACC, FRCPC
Summary, Conclusions, and Vision Statement: The Near Future of Thrombosis Reduction in the Setting of ACS and AF Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI
Faculty Panel: Interactive Question and Answer Session Faculty Panel